Meta Information
ID:digestive-enzymes
Name:
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-05-21T22:30:00Z
Model
phase-a-upgrade-claude-sonnet-4.6
Interactions
Target id:
/dietary/meal
Target name:
Any Caloric Meal
Severity:
major
Interaction type:
requirement
Nature:
temporal
Temporal spacing:
Hours before target:
0.25
Hours after target:
0
Description:
Digestive enzymes must be physically present with food to effectively break down fats, proteins, and carbohydrates as they enter the digestive tract.
Actionable advice:
It should be taken immediately before or with the first few bites of a meal for optimal effect.
Validation status:
validated_via_primary_literature
Evidence tier:
tier_b
Evidence basis:
primary_literature_verbatim
Evidence anchors:
Source url:
Exact phrase from label:
The delivery of sufficient enzyme concentrations into the duodenal lumen simultaneously with meals can reduce nutrient malabsorption, improve the symptoms of steatorrhea, and in some cases alleviate the pain associated with chronic pancreatitis.
Label source:
PubMed: Pancreatic enzyme pharmacotherapy. (PMID 17542772)
Action type:
separate
Target id:
/intervention/acarbose
Target name:
Acarbose
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Acarbose works by inhibiting carbohydrate-digesting enzymes (alpha-glucosidases). Taking supplemental amylase, a carbohydrate-digesting enzyme, directly counteracts the medication's mechanism, leading to loss of glycemic control.
Actionable advice:
Digestive enzyme formulas containing amylase should be avoided while prescribed acarbose.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mechanistic inference: supplemental carbohydrate-digesting enzymes (amylase/glucoamylase) act opposite to acarbose, an alpha-glucosidase inhibitor that intentionally slows carbohydrate digestion; co-use could blunt acarbose's glucose-lowering effect. Plausible PD opposition, unstudied.
Label source:
Class inference
Action type:
avoid
Target id:
/intervention/orlistat
Target name:
Orlistat (Xenical, Alli)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Orlistat is a weight-loss medication that functions by blocking the action of lipase, the enzyme that digests fat. Taking supplemental lipase will negate the drug's intended effect.
Actionable advice:
Digestive enzymes containing lipase should not be taken while using Orlistat.
Validation status:
validated_via_fda_label
Evidence tier:
tier_a
Evidence basis:
fda_label_verbatim
Evidence anchors:
Source url:
Exact phrase from label:
12.1 Mechanism of Action Orlistat is a reversible inhibitor of gastrointestinal lipases.
Label source:
Action type:
avoid
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants and Antiplatelets
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Certain proteolytic enzymes, such as bromelain and papain, which are common in enzyme blends, may possess blood-thinning properties that could amplify the effects of anticoagulant and antiplatelet drugs, increasing bleeding risk.
Actionable advice:
It is important to talk to a physician before using digestive enzymes while taking any blood-thinning medication.
Validation status:
validated_via_fda_label
Evidence tier:
tier_a
Evidence basis:
fda_label_verbatim
Evidence anchors:
Source url:
Exact phrase from label:
Some botanicals may cause bleeding events when taken alone (e.g., garlic and Ginkgo biloba) and may have anticoagulant, antiplatelet, and/or fibrinolytic properties.
Label source:
Action type:
informational_none
Target id:
/class/antacids
Target name:
Antacids
Severity:
moderate
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
1
Hours after target:
1
Description:
Antacids raise stomach pH, which can prematurely degrade or deactivate non-enteric-coated enzymes, particularly proteases that require an acidic environment, reducing their effectiveness.
Actionable advice:
Doses of digestive enzymes and antacids should be separated by at least one hour.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mechanistic inference: enteric-coated/pH-sensitive digestive-enzyme preparations depend on gastric pH for proper release and activity; antacids alter gastric pH and can affect enzyme performance. Formulation-dependent practical consideration.
Label source:
Class inference
Action type:
separate
Target id:
/class/acid-suppressors
Target name:
Gastric Acid Suppressors (PPIs, H2 Blockers)
Severity:
minor
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
By reducing stomach acid, these medications can impair the function of acid-dependent proteases like pepsin, potentially reducing the efficacy of certain enzyme formulas that are not designed to work in a higher pH environment.
Actionable advice:
If you use acid-suppressing drugs, consider an enteric-coated or broad-spectrum pH enzyme formula.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mechanistic inference: acid-suppressing drugs change the gastric pH environment that governs where pH-sensitive enzyme preparations dissolve and act. Formulation/practical consideration, not a quantified interaction.
Label source:
Class inference
Action type:
informational_none
Target id:
/condition/pancreatitis
Target name:
Pancreatitis (Acute or Chronic)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
While prescription enzymes are a cornerstone of chronic pancreatitis treatment, using over-the-counter supplements without medical supervision is contraindicated as it may inappropriately stimulate a damaged pancreas.
Actionable advice:
Non-prescription digestive enzymes should not be used with a history of pancreatitis; it is important to consult a doctor.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Clinical/informational: exocrine pancreatic insufficiency from chronic pancreatitis is a setting where enzyme replacement is used (prescription pancrelipase is FDA-approved for EPI). Informational indication context, not a drug-drug interaction.
Label source:
Class inference
Action type:
avoid
Target id:
/condition/cystic-fibrosis
Target name:
Cystic Fibrosis
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Cystic fibrosis causes a specific type of pancreatic insufficiency requiring high-dose, regulated, prescription Pancreatic Enzyme Replacement Therapy (PERT). Over-the-counter supplements are not potent or formulated appropriately for this condition.
Actionable advice:
Only the specific prescription enzymes (PERT) prescribed by a specialist should be used for cystic fibrosis.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Clinical/informational: pancreatic insufficiency in cystic fibrosis is a primary indication for enzyme replacement (prescription pancrelipase is FDA-approved). Informational context; OTC enzyme supplements are not substitutes for prescribed PERT.
Label source:
Class inference
Action type:
informational_none
Target id:
/condition/peptic-ulcer-disease
Target name:
Active Peptic Ulcer Disease
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
High-potency protease enzymes could theoretically irritate the mucosal lining of the stomach or small intestine, potentially exacerbating the symptoms of an active ulcer.
Actionable advice:
It is important to talk to a doctor before using digestive enzymes, especially high-protease formulas, with an active ulcer.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Low-evidence precaution: in active peptic ulcer disease, proteolytic enzyme supplements on an empty stomach are theoretically irritating to ulcerated mucosa. Informational, not a labeled interaction.
Label source:
Class inference
Action type:
informational_none
Target id:
/condition/food-allergies
Target name:
Allergies to Enzyme Sources (e.g., Pineapple, Papaya, Mold)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Enzymes are derived from various sources; for example, bromelain comes from pineapple, papain from papaya, and many others from Aspergillus mold species. An allergy to the source material can cause an allergic reaction to the supplement.
Actionable advice:
The product label should be checked for the enzyme sources, and any to which there is a known allergy should be avoided.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mechanistic/informational: digestive-enzyme products are often porcine/fungal/plant-derived and may themselves trigger allergy; they do not reliably prevent food-allergic reactions. Safety/informational note, not an interaction.
Label source:
Class inference
Action type:
avoid
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
The safety of most over-the-counter digestive enzyme supplements has not been rigorously studied in pregnant women, and some enzymes may be absorbed systemically.
Actionable advice:
It is important to talk to a healthcare provider before using digestive enzymes during pregnancy.
Validation status:
anecdotal
Evidence tier:
tier_d
Evidence basis:
anecdotal_summary
Evidence anchors:
Exact phrase from label:
Animal studies show risk and human studies are not available, or neither animal nor human studies were done
Label source:
Anecdotal: RxList
Action type:
informational_none
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
It is not known whether components of digestive enzyme supplements are passed into breast milk or what their effects might be on a nursing infant.
Actionable advice:
It is important to talk to a healthcare provider before using digestive enzymes while breastfeeding.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
NatMed Pro Monograph: Pancreatic Enzyme Products
Action type:
informational_none
Target id:
/class/viscous-fibers
Target name:
Gel-Forming Viscous Fibers (e.g., Psyllium, Glucomannan)
Severity:
minor
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
When taken in large quantities within the same meal, thick, gel-forming fibers could theoretically entrap some enzymes, slightly reducing their immediate contact with food substrates.
Actionable advice:
This interaction is generally not clinically significant, but for maximum effect, you may take enzymes with lower-fiber meals.
Validation status:
validated_via_pubmed
Evidence tier:
tier_b
Evidence basis:
pubmed_abstract_verbatim
Evidence anchors:
Source url:
Exact phrase from label:
Viscous dietary fibers thicken when mixed with fluids and include polysaccharides such as gums, pectins, psyllium, and beta-glucans.
Label source:
PubMed: Critical reviews in food science and nutrition (2006)
Source url:
Exact phrase from label:
The effect of dietary fiber viscosity on apparent ileal nitrogen and amino acid digestibility, proteolytic enzyme activity and digestive organ weights was investigated.
Label source:
PubMed: The Journal of nutrition (1994)
Source url:
Exact phrase from label:
The glycemic responses to bread products were reduced by the use of ingredients with an intact botanical or physical structure or a high amylose content or by enrichment with viscous dietary fiber.
Label source:
PubMed: The American journal of clinical nutrition (1994)
Action type:
informational_none